EUVIMEDEUVIMED entdecken
Crossref

Demographic and Clinical Characteristics of Lithium‐Treated Older Adults With Bipolar Disorder: A Replication Study From the Global Aging and Geriatric Experiments in Bipolar Disorder ( GAGE ‐ BD ) Project

Orestes V Forlenza iD, Ni Xu iD, Peijun Chen iD, Soham Rej iD, Ariel G Gildengers iD, Tomas Hajek iD, Martha Sajatovic iD, GAGE‐BD initiative

Acta Psychiatrica Scandinavica · 2025-11 · 152 (5) · 393-396

DOI: 10.1111/acps.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Psychiatrica Scandinavica, online erschienen am 10.07.2025. Verfasst von Orestes V Forlenza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, University of São Paulo, Hospital das Clínicas da Faculdade de Medicina …. Hauptthemen laut MEDLINE: Bipolar Disorder, Lithium Compounds, Antimanic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Bowden Massey Strategic Research Initiative in Bipolar Disorder Award, FAPESP, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To replicate a previous study addressing differences and similarities of older adults with bipolar disorder (OABD) treated with lithium as compared to those treated with other drugs.

Methods

Cross‐sectional analysis of a harmonized dataset of the GAGE‐BD Project, with over 2 thousand participants enrolled from two recruitment waves, with worldwide representation. Participants were allocated in two treatment groups according to the availability of information about current lithium use (Lithium, n = 754; Non‐lithium, n = 1,161). We used linear regression, linear mixed and generalized linear mixed models to examine the associations between treatment groups and other variables, with emphasis on the distribution of socio‐demographical and clinical variables, controlling for age, gender, and study site.

Results

We found statistical associations between lithium use and higher education level, as well as with bipolar‐1 subtype, and a negative association with comorbid anxiety disorder. OABD patients treated with lithium had lower scores on depression rating scales, and better overall global cognitive and functional state. Lithium users also reported having fewer cardiovascular comorbidities.

Conclusion

We found several potentially relevant differences in the clinical profile of OABD treated with lithium; nonetheless, the interpretation of the present results must take into account the methodological limitations inherent to the cross‐sectional approach and data harmonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderLithium CompoundsAntimanic AgentsHumansMaleFemaleCross-Sectional StudiesAgedMiddle AgedComorbidityAnxiety Disorders

Stichwörter der Autor:innen

OABDbipolar disorderelderlylithiumolder age bipolar disorderpharmacology

Substanzen

Lithium CompoundsAntimanic Agents

Autor:innen und Institutionen

  • Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, University of São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, HCFMUSP, São Paulo, Brazil.
  • Peking University Sixth Hospital and National Clinical Research Center for Mental Disorders, Beijing, China.
  • Peking University Institute of Mental Health and NHC Key Laboratory of Mental Health, Beijing, China.
  • Department of Psychiatry, Geriatric Psychiatry Division, Geriatric Research, Education and Clinical Center (GRECC), Case Western Reserve University School of Medicine, VA Northeast Ohio Healthcare System, Cleveland, Ohi…
  • Lady Davis Institute/Jewish General Hospital, McGill University, Montreal, Québec, Canada.
  • Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Orestes V Forlenza, Ni Xu, Peijun Chen, Soham Rej, Ariel G Gildengers, Tomas Hajek, Martha Sajatovic

Förderung

  • Bowden Massey Strategic Research Initiative in Bipolar Disorder Award
  • FAPESP
  • CNPq
  • National Institutes of Health (NIH)
  • National Center for Advancing Translational Science (NCATS)
  • Clinical and Translational Science Award (CTSA)
  • Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBioN), Minsistry of Science Technology and Innovation (MCTI, Brazil), Grants provided by Conselho Na…
  • Fundação do Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Forlenza, O. V., Xu, N., Chen, P., Rej, S., Gildengers, A. G., Hajek, T., Sajatovic, M., & GAGE‐BD initiative (2025). Demographic and Clinical Characteristics of Lithium‐Treated Older Adults With Bipolar Disorder: A Replication Study From the Global Aging and Geriatric Experiments in Bipolar Disorder ( GAGE ‐ BD ) Project. Acta Psychiatrica Scandinavica, 152(5), 393-396. https://doi.org/10.1111/acps.70016

Vancouver

Forlenza OV, Xu N, Chen P, Rej S, Gildengers AG, Hajek T, et al. Demographic and Clinical Characteristics of Lithium‐Treated Older Adults With Bipolar Disorder: A Replication Study From the Global Aging and Geriatric Experiments in Bipolar Disorder ( GAGE ‐ BD ) Project. Acta Psychiatrica Scandinavica. 2025;152(5):393-396. doi:10.1111/acps.70016

BibTeX
@article{Forlenza2025,
  author = {Forlenza, Orestes V and Xu, Ni and Chen, Peijun and Rej, Soham and Gildengers, Ariel G and Hajek, Tomas and Sajatovic, Martha and GAGE‐BD initiative, GAGE‐BD initiative},
  title = {Demographic and Clinical Characteristics of Lithium‐Treated Older Adults With Bipolar Disorder: A Replication Study From the Global Aging and Geriatric Experiments in Bipolar Disorder ( GAGE ‐ BD ) Project},
  journal = {Acta Psychiatrica Scandinavica},
  year = {2025},
  volume = {152},
  number = {5},
  pages = {393--396},
  doi = {10.1111/acps.70016}
}
Kostenlos starten →